Chemoinformaics analysis of MYRICETIN-3-O-RHAMNOSIDE
| Molecular Weight | 464.379 | nRot | 3 |
| Heavy Atom Molecular Weight | 444.219 | nRig | 24 |
| Exact Molecular Weight | 464.095 | nRing | 4 |
| Solubility: LogS | -3.971 | nHRing | 2 |
| Solubility: LogP | 0.49 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 58.0299 |
| nHD | 8 | BPOL | 26.1401 |
| QED | 0.244 |
| Synth | 4.172 |
| Natural Product Likeliness | 2.314 |
| NR-PPAR-gamma | 0.962 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.75 |
| HIA | 0.716 |
| CACO-2 | -6.332 |
| MDCK | 0.00000784 |
| BBB | 0.006 |
| PPB | 0.892335 |
| VDSS | 0.891 |
| FU | 0.134113 |
| CYP1A2-inh | 0.072 |
| CYP1A2-sub | 0.061 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.174 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.159 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.01 |
| CL | 4.48 |
| T12 | 0.864 |
| hERG | 0.062 |
| Ames | 0.734 |
| ROA | 0.036 |
| SkinSen | 0.473 |
| Carcinogencity | 0.042 |
| EI | 0.082 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.922 |
| Antiviral | Yes |
| Prediction | 0.873173 |